Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
North Eastern Germany Society of Gynaecologic Oncology
ClinicalTrials.gov Identifier:
NCT00170573
First received: September 9, 2005
Last updated: March 24, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2010
  Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)